Zacks Research Comments on Henry Schein, Inc.’s FY2024 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Zacks Research raised their FY2024 earnings per share estimates for shares of Henry Schein in a research report issued on Tuesday, April 16th. Zacks Research analyst U. Biswas now forecasts that the company will post earnings of $5.04 per share for the year, up from their prior estimate of $5.03. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $5.38 EPS.

Other research analysts also recently issued reports about the company. Jefferies Financial Group upped their price target on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. SVB Leerink initiated coverage on Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. Finally, Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $81.09.

Henry Schein Trading Down 0.3 %

Shares of NASDAQ:HSIC opened at $69.97 on Wednesday. The stock has a 50 day moving average of $74.43 and a 200 day moving average of $72.48. The company has a market cap of $8.99 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Henry Schein has a 12-month low of $60.01 and a 12-month high of $85.39.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). The company had revenue of $3.02 billion for the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company’s revenue was down 10.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.21 earnings per share.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently bought and sold shares of HSIC. Boston Partners grew its position in Henry Schein by 144.1% in the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after acquiring an additional 1,556,831 shares during the last quarter. Norges Bank bought a new position in Henry Schein in the 4th quarter valued at $111,715,000. Morgan Stanley grew its position in Henry Schein by 143.4% in the 4th quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock valued at $186,727,000 after acquiring an additional 1,377,207 shares during the last quarter. Nuance Investments LLC bought a new position in Henry Schein in the 4th quarter valued at $103,446,000. Finally, Lazard Asset Management LLC grew its position in Henry Schein by 1,303.3% in the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock valued at $92,614,000 after acquiring an additional 1,158,451 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.